| |
|
|
|
Abcam, Inc.-, Baltimore, Maryland
November 5, 2008
The meeting will cover multidrug resistance in cancer and ABC transporters - basic, clinical, regulation and drug-drug interaction aspects.
|
|
|
|
|
|
|
|
Organized by:
|
|
Abcam, Inc. |
|
|
Invited Speakers:
|
|
- Keynote: Dr Michael M. Gottesman (National Cancer Institute, NIH)
Current status of multidrug resistance and ABC transporters - Dr Robert B. Innis (Molecular Imaging Branch, NIMH)
Positron emission tomographic imaging of drug efflux transporters - Dr David S. Miller (NIEHS, NIH)
Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier - Dr Gilbert J. Burckart (U.S. Food and Drug Administration)
Drug-drug interactions and regulatory implications for membrane transporter substrates in drug development - Dr. Maria R. Baer (University of Maryland Greenebaum Cancer Center)
Clinical and therapeutic implications of multidrug resistance-associated ABC drug transporters - Dr Suresh V. Ambudkar (National Cancer Institute)
Mechanism of action of multidrug resistance-linked ABC drug transporters
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
See below
|
|
|
|
|
|
|
|
Registration:
|
|
Call for papers:
Abstracts for posters which fit within the theme of the meeting are invited. Oral abstract deadline: August 5, 2008
Poster abstract deadline: October 5, 2008 Posters will be judged. The winner will receive up to $150 off their registration for a future Abcam conference or an antibody from the Abcam catalog. Abstract submission guidelines. Registration: | | Early Bird: Register by September 5, 2008 | Standard: Register after September 5, 2008 | Regular | $125.00 | $160.00 | Student | $45.00 | $80.00 |
The registration fee includes lunch, coffee, and reception after the meeting. Register and submit your abstract today!
|
|
|
E-mail:
|
|
katie.sedat@abcam.com
|
|
|
|
|
|
|
|
|